Overview of the CSIRO Australian Animal Health Laboratory.
Identifieur interne : 001147 ( PubMed/Corpus ); précédent : 001146; suivant : 001148Overview of the CSIRO Australian Animal Health Laboratory.
Auteurs : John LowenthalSource :
- Journal of infection and public health [ 1876-035X ]
English descriptors
- KwdEn :
- Animals, Australia, Biomedical Research (methods), Communicable Diseases, Emerging (etiology), Communicable Diseases, Emerging (therapy), Communicable Diseases, Emerging (veterinary), Containment of Biohazards, Disease Transmission, Infectious (prevention & control), Humans, Laboratories, Zoonoses (etiology), Zoonoses (therapy).
- MESH :
- etiology : Communicable Diseases, Emerging, Zoonoses.
- methods : Biomedical Research.
- prevention & control : Disease Transmission, Infectious.
- therapy : Communicable Diseases, Emerging, Zoonoses.
- veterinary : Communicable Diseases, Emerging.
- Animals, Australia, Containment of Biohazards, Humans, Laboratories.
Abstract
Emerging infectious diseases arising from livestock and wildlife pose serious threats to global human health, as shown by a series of continuous outbreaks involving highly pathogenic influenza, SARS, Ebola and MERS. The risk of pandemics and bioterrorism threats is ever present and growing, but our ability to combat them is limited by the lack of available vaccines, therapeutics and rapid diagnostics. The use of high bio-containment facilities, such as the CSIRO Australian Animal Health Laboratory, plays a key role studying these dangerous pathogens and facilitates the development of countermeasures. To combat diseases like MERS, we must take a holistic approach that involves the development of early biomarkers of infection, a suite of treatment options (vaccines, anti-viral drugs and antibody therapeutics) and appropriate animal models to test the safety and efficacy of candidate treatments.
DOI: 10.1016/j.jiph.2016.04.007
PubMed: 27118215
Links to Exploration step
pubmed:27118215Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Overview of the CSIRO Australian Animal Health Laboratory.</title>
<author><name sortKey="Lowenthal, John" sort="Lowenthal, John" uniqKey="Lowenthal J" first="John" last="Lowenthal">John Lowenthal</name>
<affiliation><nlm:affiliation>Emerging Infectious Diseases Program, CSIRO Health and Biosecurity, Australia. Electronic address: john.lowenthal@csiro.au.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="????"><PubDate><MedlineDate>2016 May-Jun</MedlineDate>
</PubDate>
</date>
<idno type="RBID">pubmed:27118215</idno>
<idno type="pmid">27118215</idno>
<idno type="doi">10.1016/j.jiph.2016.04.007</idno>
<idno type="wicri:Area/PubMed/Corpus">001147</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001147</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Overview of the CSIRO Australian Animal Health Laboratory.</title>
<author><name sortKey="Lowenthal, John" sort="Lowenthal, John" uniqKey="Lowenthal J" first="John" last="Lowenthal">John Lowenthal</name>
<affiliation><nlm:affiliation>Emerging Infectious Diseases Program, CSIRO Health and Biosecurity, Australia. Electronic address: john.lowenthal@csiro.au.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series><title level="j">Journal of infection and public health</title>
<idno type="eISSN">1876-035X</idno>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term>
<term>Australia</term>
<term>Biomedical Research (methods)</term>
<term>Communicable Diseases, Emerging (etiology)</term>
<term>Communicable Diseases, Emerging (therapy)</term>
<term>Communicable Diseases, Emerging (veterinary)</term>
<term>Containment of Biohazards</term>
<term>Disease Transmission, Infectious (prevention & control)</term>
<term>Humans</term>
<term>Laboratories</term>
<term>Zoonoses (etiology)</term>
<term>Zoonoses (therapy)</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Communicable Diseases, Emerging</term>
<term>Zoonoses</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Biomedical Research</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Disease Transmission, Infectious</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Communicable Diseases, Emerging</term>
<term>Zoonoses</term>
</keywords>
<keywords scheme="MESH" qualifier="veterinary" xml:lang="en"><term>Communicable Diseases, Emerging</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Animals</term>
<term>Australia</term>
<term>Containment of Biohazards</term>
<term>Humans</term>
<term>Laboratories</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Emerging infectious diseases arising from livestock and wildlife pose serious threats to global human health, as shown by a series of continuous outbreaks involving highly pathogenic influenza, SARS, Ebola and MERS. The risk of pandemics and bioterrorism threats is ever present and growing, but our ability to combat them is limited by the lack of available vaccines, therapeutics and rapid diagnostics. The use of high bio-containment facilities, such as the CSIRO Australian Animal Health Laboratory, plays a key role studying these dangerous pathogens and facilitates the development of countermeasures. To combat diseases like MERS, we must take a holistic approach that involves the development of early biomarkers of infection, a suite of treatment options (vaccines, anti-viral drugs and antibody therapeutics) and appropriate animal models to test the safety and efficacy of candidate treatments. </div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">27118215</PMID>
<DateCompleted><Year>2017</Year>
<Month>01</Month>
<Day>30</Day>
</DateCompleted>
<DateRevised><Year>2020</Year>
<Month>04</Month>
<Day>01</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1876-035X</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>9</Volume>
<Issue>3</Issue>
<PubDate><MedlineDate>2016 May-Jun</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Journal of infection and public health</Title>
<ISOAbbreviation>J Infect Public Health</ISOAbbreviation>
</Journal>
<ArticleTitle>Overview of the CSIRO Australian Animal Health Laboratory.</ArticleTitle>
<Pagination><MedlinePgn>236-9</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jiph.2016.04.007</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S1876-0341(16)30024-7</ELocationID>
<Abstract><AbstractText>Emerging infectious diseases arising from livestock and wildlife pose serious threats to global human health, as shown by a series of continuous outbreaks involving highly pathogenic influenza, SARS, Ebola and MERS. The risk of pandemics and bioterrorism threats is ever present and growing, but our ability to combat them is limited by the lack of available vaccines, therapeutics and rapid diagnostics. The use of high bio-containment facilities, such as the CSIRO Australian Animal Health Laboratory, plays a key role studying these dangerous pathogens and facilitates the development of countermeasures. To combat diseases like MERS, we must take a holistic approach that involves the development of early biomarkers of infection, a suite of treatment options (vaccines, anti-viral drugs and antibody therapeutics) and appropriate animal models to test the safety and efficacy of candidate treatments. </AbstractText>
<CopyrightInformation>Copyright © 2016 King Saud Bin Abdulaziz University for Health Sciences. Published by Elsevier Ltd. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lowenthal</LastName>
<ForeName>John</ForeName>
<Initials>J</Initials>
<AffiliationInfo><Affiliation>Emerging Infectious Diseases Program, CSIRO Health and Biosecurity, Australia. Electronic address: john.lowenthal@csiro.au.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2016</Year>
<Month>04</Month>
<Day>24</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>England</Country>
<MedlineTA>J Infect Public Health</MedlineTA>
<NlmUniqueID>101487384</NlmUniqueID>
<ISSNLinking>1876-0341</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D001315" MajorTopicYN="N">Australia</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D035843" MajorTopicYN="N">Biomedical Research</DescriptorName>
<QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D021821" MajorTopicYN="N">Communicable Diseases, Emerging</DescriptorName>
<QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
<QualifierName UI="Q000662" MajorTopicYN="Y">veterinary</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003264" MajorTopicYN="Y">Containment of Biohazards</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018562" MajorTopicYN="N">Disease Transmission, Infectious</DescriptorName>
<QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007753" MajorTopicYN="Y">Laboratories</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015047" MajorTopicYN="N">Zoonoses</DescriptorName>
<QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Emerging infectious diseases</Keyword>
<Keyword MajorTopicYN="N">High-biocontainment</Keyword>
<Keyword MajorTopicYN="N">MERS</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year>
<Month>03</Month>
<Day>21</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised"><Year>2016</Year>
<Month>04</Month>
<Day>08</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2016</Year>
<Month>04</Month>
<Day>12</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2016</Year>
<Month>4</Month>
<Day>28</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2016</Year>
<Month>4</Month>
<Day>28</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2017</Year>
<Month>1</Month>
<Day>31</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">27118215</ArticleId>
<ArticleId IdType="pii">S1876-0341(16)30024-7</ArticleId>
<ArticleId IdType="doi">10.1016/j.jiph.2016.04.007</ArticleId>
<ArticleId IdType="pmc">PMC7102798</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Nat Rev Immunol. 2003 Jan;3(1):79-84</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12511878</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Nature. 2008 Feb 21;451(7181):990-3</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18288193</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Emerg Infect Dis. 2014 Mar;20(3):372-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24572697</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Expert Rev Vaccines. 2015 Jul;14(7):949-62</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25864502</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001147 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 001147 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= MersV1 |flux= PubMed |étape= Corpus |type= RBID |clé= pubmed:27118215 |texte= Overview of the CSIRO Australian Animal Health Laboratory. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:27118215" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \ | NlmPubMed2Wicri -a MersV1
![]() | This area was generated with Dilib version V0.6.33. | ![]() |